US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

MGRX Mangoceuticals Inc

0.3197

0.0047 (1.49%)

26 Jun 2024 - Cerrado

Retrasado por 15 minutos

Form EFFECT - Notice of Effectiveness

Mangoceuticals (NASDAQ:MGRX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Mangoceuticals.

Mangoceuticals (NASDAQ:MGRX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Mangoceuticals.

Noticias sobre Mangoceuticals Inc MGRX

Form 144 - Report of proposed sale of securities
Martes 18 de Junio 2024 (1 semana hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 10 de Junio 2024 (2 semanas hace) • Edgar (US Regulatory)

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
Jueves 6 de Junio 2024 (3 semanas hace) • GlobeNewswire Inc.

Form 8-K - Current report
Miércoles 5 de Junio 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 5 de Junio 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 5 de Junio 2024 (3 semanas hace) • Edgar (US Regulatory)

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies
Martes 4 de Junio 2024 (3 semanas hace) • GlobeNewswire Inc.

MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances
Martes 4 de Junio 2024 (3 semanas hace) • GlobeNewswire Inc.

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets
Martes 28 de Mayo 2024 (4 semanas hace) • GlobeNewswire Inc.

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts
Jueves 23 de Mayo 2024 (1 mes hace) • GlobeNewswire Inc.

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications
Martes 21 de Mayo 2024 (1 mes hace) • GlobeNewswire Inc.

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration
Jueves 16 de Mayo 2024 (1 mes hace) • GlobeNewswire Inc.

Más de Mangoceuticals Inc Artículos de Noticias

NLBNPIT1UIV8 20351221 27...

Huffington Capital

Achari Ventures Holdings...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones